Literature DB >> 25538209

CRISPR-Cas9 genome editing of a single regulatory element nearly abolishes target gene expression in mice--brief report.

Yu Han1, Orazio J Slivano1, Christine K Christie1, Albert W Cheng1, Joseph M Miano2.   

Abstract

OBJECTIVE: To ascertain the importance of a single regulatory element in the control of Cnn1 expression using CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) genome editing. APPROACH AND
RESULTS: The CRISPR/Cas9 system was used to produce 3 of 18 founder mice carrying point mutations in an intronic CArG box of the smooth muscle cell-restricted Cnn1 gene. Each founder was bred for germline transmission of the mutant CArG box and littermate interbreeding to generate homozygous mutant (Cnn1(ΔCArG/ΔCArG)) mice. Quantitative reverse transcription polymerase chain reaction, Western blotting, and confocal immunofluorescence microscopy showed dramatic reductions in Cnn1 mRNA and CNN1 protein expression in Cnn1(ΔCArG/ΔCArG) mice with no change in other smooth muscle cell-restricted genes and little evidence of off-target edits elsewhere in the genome. In vivo chromatin immunoprecipitation assay revealed a sharp decrease in binding of serum response factor to the mutant CArG box. Loss of CNN1 expression was coincident with an increase in Ki-67 positive cells in the normal vessel wall.
CONCLUSIONS: CRISPR/Cas9 genome editing of a single CArG box nearly abolishes Cnn1 expression in vivo and evokes increases in smooth muscle cell DNA synthesis. This facile genome editing system paves the way for a new generation of studies designed to test the importance of individual regulatory elements in living animals, including regulatory variants in conserved sequence blocks linked to human disease.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  CArG box; CRISPR; mice, transgenic; muscle, smooth; serum response factor

Mesh:

Substances:

Year:  2014        PMID: 25538209      PMCID: PMC4304932          DOI: 10.1161/ATVBAHA.114.305017

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

1.  One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.

Authors:  Hui Yang; Haoyi Wang; Chikdu S Shivalila; Albert W Cheng; Linyu Shi; Rudolf Jaenisch
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems.

Authors:  Wei Li; Fei Teng; Tianda Li; Qi Zhou
Journal:  Nat Biotechnol       Date:  2013-08       Impact factor: 54.908

3.  Effective gene targeting in rabbits using RNA-guided Cas9 nucleases.

Authors:  Dongshan Yang; Jie Xu; Tianqing Zhu; Jianglin Fan; Liangxue Lai; Jifeng Zhang; Y Eugene Chen
Journal:  J Mol Cell Biol       Date:  2014-01-08       Impact factor: 6.216

4.  Serum response factor-dependent regulation of the smooth muscle calponin gene.

Authors:  J M Miano; M J Carlson; J A Spencer; R P Misra
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

5.  Regulation of 130-kDa smooth muscle myosin light chain kinase expression by an intronic CArG element.

Authors:  Meng Chen; Wenwu Zhang; Xiao Lu; April M Hoggatt; Susan J Gunst; Ghassan S Kassab; Johnathan D Tune; B Paul Herring
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

6.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

Review 7.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

8.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

9.  One-step generation of knockout pigs by zygote injection of CRISPR/Cas system.

Authors:  Tang Hai; Fei Teng; Runfa Guo; Wei Li; Qi Zhou
Journal:  Cell Res       Date:  2014-01-31       Impact factor: 25.617

10.  Fine tuning of craniofacial morphology by distant-acting enhancers.

Authors:  Catia Attanasio; Alex S Nord; Yiwen Zhu; Matthew J Blow; Zirong Li; Denise K Liberton; Harris Morrison; Ingrid Plajzer-Frick; Amy Holt; Roya Hosseini; Sengthavy Phouanenavong; Jennifer A Akiyama; Malak Shoukry; Veena Afzal; Edward M Rubin; David R FitzPatrick; Bing Ren; Benedikt Hallgrímsson; Len A Pennacchio; Axel Visel
Journal:  Science       Date:  2013-10-25       Impact factor: 47.728

View more
  29 in total

Review 1.  A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research.

Authors:  Joseph M Miano; Qiuyu Martin Zhu; Charles J Lowenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-21       Impact factor: 8.311

Review 2.  Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders.

Authors:  N Coll-Bonfill; B de la Cruz-Thea; M V Pisano; M M Musri
Journal:  Pflugers Arch       Date:  2016-04-25       Impact factor: 3.657

Review 3.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

Review 4.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

5.  Directed evolution studies of a thermophilic Type II-C Cas9.

Authors:  Travis H Hand; Anuska Das; Hong Li
Journal:  Methods Enzymol       Date:  2018-12-28       Impact factor: 1.600

6.  Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.

Authors:  Danny Halim; Michael P Wilson; Daniel Oliver; Erwin Brosens; Joke B G M Verheij; Yu Han; Vivek Nanda; Qing Lyu; Michael Doukas; Hans Stoop; Rutger W W Brouwer; Wilfred F J van IJcken; Orazio J Slivano; Alan J Burns; Christine K Christie; Karen L de Mesy Bentley; Alice S Brooks; Dick Tibboel; Suowen Xu; Zheng Gen Jin; Tono Djuwantono; Wei Yan; Maria M Alves; Robert M W Hofstra; Joseph M Miano
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-14       Impact factor: 11.205

7.  CRISPR-Cas9-Mediated Epitope Tagging Provides Accurate and Versatile Assessment of Myocardin-Brief Report.

Authors:  Qing Lyu; Vidhi Dhagia; Yu Han; Bing Guo; Mary E Wines-Samuelson; Christine K Christie; Qiangzong Yin; Orazio J Slivano; Paul Herring; Xiaochun Long; Sachin A Gupte; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 8.  A history of genome editing in mammals.

Authors:  Almudena Fernández; Santiago Josa; Lluis Montoliu
Journal:  Mamm Genome       Date:  2017-06-06       Impact factor: 2.957

9.  Coronary Disease-Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway.

Authors:  Manabu Nagao; Qing Lyu; Quanyi Zhao; Robert C Wirka; Joetsaroop Bagga; Trieu Nguyen; Paul Cheng; Juyong Brian Kim; Milos Pjanic; Joseph M Miano; Thomas Quertermous
Journal:  Circ Res       Date:  2019-12-09       Impact factor: 17.367

10.  Phosphate Lock Residues of Acidothermus cellulolyticus Cas9 Are Critical to Its Substrate Specificity.

Authors:  Travis H Hand; Anuska Das; Mitchell O Roth; Chardasia L Smith; Uriel L Jean-Baptiste; Hong Li
Journal:  ACS Synth Biol       Date:  2018-12-03       Impact factor: 5.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.